LONDON (Reuters) - Britain is to stop using GlaxoSmithKline's cervical cancer vaccine Cervarix from next September and will instead offer girls Merck & Co's rival product Gardasil. The move underscores Gardasil's lead in a $1 billion-plus worldwide ... UK switches to Merck's Gardasil for HPV vaccination
Thursday, November 24, 2011
UK switches to Merck's Gardasil for HPV vaccination
LONDON (Reuters) - Britain is to stop using GlaxoSmithKline's cervical cancer vaccine Cervarix from next September and will instead offer girls Merck & Co's rival product Gardasil. The move underscores Gardasil's lead in a $1 billion-plus worldwide ... UK switches to Merck's Gardasil for HPV vaccination
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment